Entry |
|
Name |
|
Gene |
BRAF B-Raf proto-oncogene, serine/threonine kinase [KO: K04365]
|
Organism |
hsa_var Human gene variants (Homo sapiens)
|
Variation |
|
Variation |
|
Network |
|
Disease |
|
Drug target |
|
Reference |
|
Authors |
Kondo T, Ezzat S, Asa SL. |
Title |
Pathogenetic mechanisms in thyroid follicular-cell neoplasia. |
Journal |
|
Reference |
|
Authors |
Li DD, Zhang YF, Xu HX, Zhang XP |
Title |
The role of BRAF in the pathogenesis of thyroid carcinoma. |
Journal |
Front Biosci (Landmark Ed) 20:1068-78 (2015) DOI: 10.2741/4359 |
Reference |
|
Authors |
Richtig G, Hoeller C, Kashofer K, Aigelsreiter A, Heinemann A, Kwong LN, Pichler M, Richtig E |
Title |
Beyond the BRAF(V)(600E) hotspot: biology and clinical implications of rare BRAF gene mutations in melanoma patients. |
Journal |
|
Reference |
|
Authors |
Guadarrama-Orozco JA, Ortega-Gomez A, Ruiz-Garcia EB, Astudillo-de la Vega H, Meneses-Garcia A, Lopez-Camarillo C |
Title |
Braf V600E mutation in melanoma: translational current scenario. |
Journal |
|
Reference |
|
Authors |
Sosman JA, Kim KB, Schuchter L, Gonzalez R, Pavlick AC, Weber JS, McArthur GA, Hutson TE, Moschos SJ, Flaherty KT, Hersey P, Kefford R, Lawrence D, Puzanov I, Lewis KD, Amaravadi RK, Chmielowski B, Lawrence HJ, Shyr Y, Ye F, Li J, Nolop KB, Lee RJ, Joe AK, Ribas A |
Title |
Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib. |
Journal |
|